Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 158

    Canada to create national drug agency to cut cost of prescription medicines

    Canada to create national drug agency to cut cost of prescription medicines

    Farhat Nasim21 March 2019 9:30 AM IST
    Branded medicines cost, on average, 20 per cent more in Canada than in other advanced economies, and around 20 per cent of Canadians are uninsured or...
    GSK reports positive data from trial of cancer drug Dostarlimab

    GSK reports positive data from trial of cancer drug Dostarlimab

    Garima21 March 2019 9:15 AM IST
    GSK said it would apply for marketing approval for Dostarlimab in endometrial cancer at the end of 2019.New Delhi: GlaxoSmithKline said on Tuesday a...
    NY mulls medication assisted opioid treatment in all lockups

    NY mulls medication assisted opioid treatment in all lockups

    Farhat Nasim21 March 2019 9:00 AM IST
    Experts say drugs such as methadone and suboxone can greatly improve inmates' chances of recovery and reduce the risk that they will commit other...
    Zydus Cadila gets USFDA nod to antiviral ointment Acyclovir

    Zydus Cadila gets USFDA nod to antiviral ointment Acyclovir

    Farhat Nasim20 March 2019 10:00 AM IST
    Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market generic Acyclovir ointment USP 5...
    Novartis division Alcon acquires Power Vision

    Novartis division Alcon acquires Power Vision

    Garima20 March 2019 9:47 AM IST
    Under the terms of the agreement, Alcon, a Novartis division paid USD 285 million to PowerVision at closing with additional payments based on...
    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Merck, Enigma Biomedical signs license agreement for Novel MK 6884 Imaging Agent

    Garima20 March 2019 9:46 AM IST
    As part of the agreement with Merck, EBG will be responsible for the clinical development and commercialization of MK-6884 in return for payment of...
    Blackstone belatedly buys into Abenomics

    Blackstone belatedly buys into Abenomics

    Garima20 March 2019 9:45 AM IST
    After focusing mainly on real estate, Blackstone's maiden Japanese acquisition doesn't fit the common country playbook of a corporate carveout. More...
    BD gets USFDA approval for Venovo Stent to treat Venous Occlusive Disease

    BD gets USFDA approval for Venovo Stent to treat Venous Occlusive Disease

    Farhat Nasim20 March 2019 9:15 AM IST
    FRANKLIN: BD (Becton, Dickinson and Company) global medical technology company, recently announced the U.S. Food and Drug Administration has granted...
    Dr Reddys launches B2B Customer Service Portal XCEED

    Dr Reddys launches B2B Customer Service Portal XCEED

    Garima19 March 2019 10:00 AM IST
    Dr Reddys launch of XCEED gives now instant access to an industry-leading portfolio which spans across a wide range of indications and complex...
    Alembic Pharma raises Rs 150 crore via NCDs

    Alembic Pharma raises Rs 150 crore via NCDs

    Garima19 March 2019 9:45 AM IST
    "The NCD Committee of Alembic Pharma Ltd at its meeting held today has allotted 1,500, 8.37 per cent unsecured listed rated redeemable NCDs of Rs...
    Roche Tecentriq, chemotherapy combo wins USFDA approval for treatment of lung cancer

    Roche Tecentriq, chemotherapy combo wins USFDA approval for treatment of lung cancer

    Farhat Nasim19 March 2019 9:30 AM IST
    New Delhi: Swiss drugmaker Roche Holding AG's U.S. unit Genentech said on Monday its immunotherapy Tecentriq won approval for a tough-to-treat type of...
    United Health Group OptumRx accused of drug overcharges

    United Health Group OptumRx accused of drug overcharges

    Farhat Nasim19 March 2019 9:00 AM IST
    Yost accused OptumRx of failing for nearly three years to provide agreed-upon discounts for generic drugs purchased by injured workers submitting...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok